On the basis of technical support such as the establishment of a technology center and research and development center, VICTOR has established a management office and expert committee to coordinate the operation and implementation of the enterprise research institute. It has multiple institutions including innovative drug synthesis, generic drug synthesis, new drug research, quality research, process transformation research, information intelligence, and intellectual property research. The company has a relatively complete talent structure from synthesis, extraction, analysis, formulation to new drug approval, and a group of experienced pilot scale technicians, laying a solid foundation for the large-scale production of new drugs; The company currently has a research and development team of several hundred people, 90% of whom are undergraduate or above graduates from pharmaceutical universities. They have strong abilities in developing innovative drugs. The company also has extensive exchanges with well-known domestic research institutions and has established good cooperation to achieve the goal of improving the company's research level and personnel quality.

  The company hires experts as consultants all year round and establishes a comprehensive expert consultation and technical support system. The company currently has multiple new drugs and generic projects under development, laying a solid foundation for the development of new products.